anonymous
Guest
anonymous
Guest
Eli Lilly surpassed earnings expectations for the third quarter of 2019 but revenues came in shy of estimates. Total revenue grew 3% year-over-year to $5.47 billion, but fell short of estimates of $5.5 billion. Revenues grew 4% excluding foreign currency impacts. Revenue growth was driven by an 8% increase in volume. Read more